FDA video warning on metoclopramide and tardive dyskinesia

On February 2009 the FDA required all manufacturers of metoclopramide to include a boxed warning about the risks of developing tardive diskynesia after chronic use.

Now the agency issues a patient safety warning on the same topic. This has brought about some legal implications, many law firms now offer legal representation for patients who suffered metoclopramide side effects.


This neurology video shows some more examples of patients that suffer tardive dyskinesia.


Illustrated Psychopharmacology Lectures in Your Inbox

  • Mechanisms of action, adverse effects and indications of psychotropic medications.
  • Concise and illustrated presentations.¬†
  • Practical tips for mental health professionals.




Are you a visual learner interested in learning psychopharmacology? Click here to get our videos